Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis
Leptomeningeal metastases from solid tumors are a rare complication with a very poor prognosis. Here the authors report the efficacy and safety of combined ipilimumab and nivolumab in patients with leptomeningeal carcinomatosis.
Autori principali: | Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Quant Lee, Nancy Wang, Justine V. Cohen, Ugonma Chukwueke, Deborah Anne Forst, April Eichler, Beth Overmoyer, Nancy U. Lin, Wendy Y. Chen, Aditya Bardia, Dejan Juric, Ibiayi Dagogo-Jack, Michael D. White, Jorg Dietrich, Naema Nayyar, Albert E. Kim, Christopher Alvarez-Breckenridge, Maura Mahar, Joana L. Mora, Brian V. Nahed, Pamela S. Jones, Helen A. Shih, Elizabeth R. Gerstner, Anita Giobbie-Hurder, Scott L. Carter, Kevin Oh, Daniel P. Cahill, Ryan J. Sullivan |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Nature Portfolio
2021-10-01
|
Serie: | Nature Communications |
Accesso online: | https://doi.org/10.1038/s41467-021-25859-y |
Documenti analoghi
Documenti analoghi
-
Leptomeningeal carcinomatosis or ischemic cerebrovascular disease?
di: Ayelet Eran, et al.
Pubblicazione: (2021-05-01) -
Leptomeningeal Carcinomatosis with Delayed Ocular Manifestations
di: Craig Czyz, et al.
Pubblicazione: (2021-02-01) -
Multiple Dural Tuberculomas Presenting as Leptomeningeal Carcinomatosis
di: Hasan Kocaeli, et al.
Pubblicazione: (2011-01-01) -
Literature Review: Role of Neurosurgery in Leptomeningeal Carcinomatosis
di: Thaís Mitie Ogasawara, et al.
Pubblicazione: (2023-12-01) -
Leptomeningeal Carcinomatosis in a Patient with Ovarian Cancer
di: Özlem Kayım Yıldız
Pubblicazione: (2019-09-01)